Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Landvik, N E ^a   Tekpli, X ^a   Anmarkrud, K H ^a   Haugen, A ^a   Zienolddiny, S ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

Carcinogenesis; Inflammation; Lung cancer; SNP; YY1

Indexed keywords

INTERLEUKIN 1BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR YY1;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; YY1 TRANSCRIPTION FACTOR;

EID: 84867141446     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21910     Document Type: Article

References (29)

1. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007; 121: 2373-2380.
2. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol 2011; 173: 259-270.
3. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008; 11: 1-15.
4. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149: 13-20.
5. Dinarello CA. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 2006; 25: 307-313.
6. Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, Zienolddiny S. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 2009; 30: 1186-1192.
7. Cahill CM, Waterman WR, Xie Y, Auron PE, Calderwood SK. Transcriptional repression of the prointerleukin 1beta gene by heat shock factor 1. J Biol Chem 1996; 271: 24874-24879.
8. Lind H, Haugen A, Zienolddiny S. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 2007; 38: 43-48.
9. Yang Z, Wara-Aswapati N, Chen C, Tsukada J, Auron PE. NF-IL6 (C/EBPbeta) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. J Biol Chem 2000; 275: 21272-21277.
10. Xie Y, Chen C, Stevenson MA, Auron PE, Calderwood SK. Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6. J Biol Chem 2002; 277: 11802-11810.
11. Stewart JJ, Stargell LA. The stability of the TFIIA-TBP-DNA complex is dependent on the sequence of the TATAAA element. J Biol Chem 2001; 276: 30078-30084.
12. Stewart JJ, Fischbeck JA, Chen X, Stargell LA. Non-optimal TATA elements exhibit diverse mechanistic consequences. J Biol Chem 2006; 281: 22665-22673.
13. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-529.
14. Hart K, Haugen A, Zienolddiny S. Allele-specific induction of IL1B -31T/C promoter polymorphism by lung carcinogens. Mutat Res 2008; 656: 14-18.
15. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 2006; 25: 1125-1142.
16. Bonavida B, Baritaki S. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-kappaB/Snail/YY1/RKIP circuitry. Nitric Oxide 2011; 24: 1-7.
17. Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors. Cell Cycle 2010; 9: 512-522.
18. Tekpli X, Rivedal E, Gorria M, et al. The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicol Appl Pharmacol 2010; 242: 231-240.
19. Dahl JA. Collas P A. quick and quantitative chromatin immunoprecipitation assay for small cell samples. Front Biosci 2007; 12: 4925-4931.
20. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 2004; 109: 353-356.
21. Joo M, Wright JG, Hu NN, et al. Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1219-L1226.
22. Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1997; 1332: F49-F66.
23. Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: Oxyradical overload diseases. Proc Natl Acad Sci USA 2000; 97: 12770-12775.
24. Auron PE, Webb AC. Interleukin-1: A gene expression system regulated at multiple levels. Eur Cytokine Netw 1994; 5: 573-592.
25. Arndt KM, Wobbe CR, Ricupero-Hovasse S, Struhl K, Winston F. Equivalent mutations in the two repeats of yeast TATA-binding protein confer distinct TATA recognition specificities. Mol Cell Biol 1994; 14: 3719-3728.
26. Tsuchiya T, Okada M, Ueda M, Yasukochi Y. Activation of the erythropoietin promoter by a point mutation from GATA to TATA in the -30 region. J Biochem 1997; 121: 193-196.
27. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: Inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 1996; 16: 4744-4753.
28. Lu SY, Rodriguez M, Liao WS. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol 1994; 14: 6253-6263.
29. Bauknecht T, See RH, Shi Y. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J Virol 1996; 70: 7695-7705.